FDA will crack down on genetic tests marketed to consumers

July 2010

FDA will crack down on genetic tests marketed to consumers....

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Controlled Substances Prescription Drug Monitoring Programs (PDMPs) to combat prescription drug abuse and diversion
Respiratory & Allergy whether it's okay to give beta-blockers to patients with chronic obstructive pulmonary disease (COPD)
Respiratory & Allergy interactions between salmeterol and strong CYP3A4 inhibitors...clarithromycin, itraconazole, ritonavir, etc
what lab tests are needed for certain drugs
Gastroenterology limit use of PPIs (omeprazole, etc)
Women's Health new oral contraceptive called Natazia (estradiol valerate/dienogest)
Vitamins & Minerals how much vitamin D is too much
Diabetes which diabetes patients should take aspirin
FDA will crack down on genetic tests marketed to consumers
Bites & Stings What really works to repel mosquitoes, ticks, and other insects
Neurology & Pain new warnings about tramadol abuse and suicide
Neurology & Pain more emphasis on using LOWER starting doses of hydromorphone (Dilaudid, etc)
Men's Health controversy about using testosterone in older men